March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
March 25, 2024
Pharmacy Times highlighted a presentation from the University of Cincinnati's Shawn Xiong discussing the potential for artificial intelligence and machine learning to bolster pharmaceutical development and research.
August 19, 2024
Rio Grande Valley, Texas news station KRGV-TV highlighted University of Cincinnati Cancer Center researcher Andrew Frankart's new trial testing lattice therapy to provide more targeted radiation for patients with large tumors.
August 5, 2024
The Cincinnati Business Courier reports construction crews broke ground in July on the final phase of the University of Cincinnati Cancer Center's Blood Cancer Healing Center, which will see the fourth and fifth floors of the building fit out with increased patient care and research infrastructure.
August 1, 2024
The University of Cincinnati's Susan McElroy was featured in an NBC News article discussing how GLP-1 weight loss drugs may trigger eating disorders in some patients.
August 8, 2024
The University of Cincinnati's Dan Bebo spoke with Fox 19 about how marijuana usage is just as dangerous as alcohol when it comes to operating a vehicle.
August 28, 2024
The University of Cincinnati's Stephen Rush, MD, joined WVXU's Cincinnati Edition to discuss the Food and Drug Administration's declining to approve MDMA-assisted therapy for PTSD.
August 20, 2024
WVXU highlighted the University of Cincinnati's Daniel Sun, who is studying the potential of using magnetic nanoparticles as a delivery system for drugs to reach the inner ear to treat hearing loss.
August 19, 2024
Funded by a National Institutes of Health career development grant, University of Cincinnati researcher Daniel Sun is studying the potential of using magnetic nanoparticles as a delivery system for drugs to reach the inner ear to treat hearing loss.